Status Epilepticus Differential Diagnoses

  • Author: Julie L Roth, MD; Chief Editor: Stephen A Berman, MD, PhD, MBA   more...
 
Updated: May 26, 2011
 
 

Diagnostic Considerations

Recognition of status epilepticus (SE) may be easy or difficult. SE in the patient with sequential, generalized major motor convulsions is obvious; the patient with nonconvulsive or subtle SE presents a diagnostic dilemma.

Nonepileptic seizures (NES), formerly called psychogenic seizures, may at times be indistinguishable from generalized convulsive SE. The risk in such cases is that the physician may immediately assume that a neurologic emergency was present and embark on an aggressive course of pharmacotherapy, neglecting physical examination and historical information.[43] A brief period of observation for atypical features (see Physical Examination) may lead to the conclusion that the patient has nonepileptic seizures and does not need anticonvulsant therapy.

In one study, unresponsiveness without movement was the most common presentation of psychogenic SE.[43] Other reviews of psychogenic SE note other frequently seen presentations, including asynchronous extremity movement, forward pelvic thrusting, and geotropic eye movements (a physical finding that indicates the eyes deviating toward the ground in a nonphysiologic manner whether the head is turned left or right).[44]

A retrospective study from one institution noted that patients with psychogenic nonepileptic SE were younger, had implanted port devices for intravenous medication administration, had lower creatine kinase levels, and received higher doses of benzodiazepines compared with patients with generalized convulsive SE epilepticus.[45]

NES is associated with several behavioral characteristics that help distinguish it from a nonepileptic event. Motor activity during an NES often is punctuated by brief periods of rest, whereas epileptic convulsions are usually sustained without pause until the end of each individual seizure.

When seizure activity spreads during an epileptic seizure, it usually follows the organization of the homunculus. NES may fail to show this stereotypical and predictable evolution of behavior.

Behaviors such as pelvic thrusting, head turning from side to side, and bizarre vocalizations are usually not seen in epileptic seizures. The exception to this rule is seizure of frontal-lobe onset.

Although clinical features are usually helpful, the ultimate test to differentiate between epileptic seizures and NES is EEG.

Simple partial status epilepticus

Given the relative rarity of simple partial SE (SPSE), maintain a high degree of skepticism before considering this diagnosis. Other common processes (eg, vascular CNS insult) and other focal processes may mimic this rare entity; keep these well in mind, especially when tempted to apply increasingly risky treatment strategies. Invest more time in confirming the diagnosis and in deliberately observing the effect of each successive treatment.

The list of alternative diagnoses for SPSE is a subset of the list associated with complex partial SE (CPSE). These include the following:

  • Transient ischemia attack (TIA) and stroke
  • Migraine and its attendant neurologic phenomena (eg, sensory, visual)
  • Transient postictal phenomena analogous to Todd paresis
  • Ophthalmic disorders (eg, retinal detachment), which may mimic visual simple partial (occipital) SE
  • Peripheral neurologic syndromes and
  • Somatoform disorders

Diagnosing SPSE is understandably easiest when it arises in a patient with an established history of focal epilepsy. Evolution of SPSE from or to a clinically overt complex partial or secondarily generalized seizure also permits accurate diagnosis.

Given that confirming SPSE on clinical grounds alone may be difficult, EEG validation can be especially important. However, the yield of EEG in detecting simple partial seizure activity is variable.

Complex partial status epilepticus

CPSE is associated with more differential diagnoses than SPSE because of its variable clinical manifestations and associated altered consciousness. In addition to TIA, stroke, and migraine, other key disturbances of CNS function that mimic CPSE include toxic or metabolic encephalopathy, delirium of diverse etiologies, and transient global amnesia.

Absence SE (persistent generalized 3-Hz spike-and-wave activity) may be clinically indistinguishable from CPSE. Prolonged postictal states may closely resemble, and are more common than, CPSE.

Psychiatric causes of decreased responsiveness resembling CPSE are familiar to many tertiary epilepsy referral centers. These include severe mood disorders, psychotic disorders, and related nonepileptic phenomena (ie, pseudo-CPSE).

Periodic lateralized epileptiform discharges (PLEDs) may occur with and without focal SE. In focal SE, PLEDs may represent an ictal correlate. This interpretation is supported by an overt clinical correlate (ie, focal twitching) or by improvement in the patient's findings on neurologic examination after PLED resolution, as may occur after treatment.

However, such clinical improvement may lag the disappearance of PLEDs by hours owing to residual postictal CNS dysfunction. Marked evolution of PLEDs, such as abrupt frequency or amplitude changes, may also signify an ictal correlate. Whether the absolute discharge frequency reliably differentiates interictal from ictal PLEDs remains controversial.

Single-photon emission computed tomography (SPECT) may assist in distinguishing ictal and interictal PLEDs in the setting of possible focal SE.[46] In instances of PLEDs in focal SE, SPECT may show focal hyperperfusion.[47]

Apart from focal SE, PLEDs often represent an interictal finding associated with acute structural CNS lesions (eg, infarct, tumor, infection) or a chronic CNS lesion with a new, superimposed systemic disturbance. In this setting, PLEDs are still associated with seizures in 70-80% of cases. Both focal SE and PLEDs arise from similar clinical contexts, and both imply an increased risk of future seizures and epilepsy.

Epilepsy partialis continua

For epilepsy partialis continua (EPC), with its associated semirhythmic, repetitive muscle twitching, the differential diagnosis is a bit different from that of SPSE and CPSE. Other entities to consider include nonepileptic myoclonus, such as those of basal ganglia, brainstem, or spinal origin. The coexistence of other overt complex partial and secondarily generalized seizures and epileptiform changes in the EEG help make this distinction.

A finding of bilateral or multifocal myoclonic process argues against focal epilepsy. Multifocal myoclonus is frequently encountered in very ill, hospitalized patients, often after systemic hypoxemia, though it is occasionally related to medications or metabolic derangements.

Other movement disorders (eg, choreiform disorders, hemiballismus, tic disorders, opsoclonus-myoclonus syndrome) might theoretically be mistaken for EPC. Careful evaluation of the movements, EEG, and accompanying history may assist in differentiation. Finally, a psychogenic process may emulate EPC in rare cases.

Differential Diagnoses

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Julie L Roth, MD  Neurologist, Epilepsy and General Neurology, Comprehensive Epilepsy Program, Rhode Island Hospital; Assistant Professor, Department of Neurology, The Warren Alpert Medical School of Brown University

Julie L Roth, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society

Disclosure: Nothing to disclose.

Coauthor(s)

Andrew S Blum, MD, PhD  Director, Adult Epilepsy and EEG Laboratory, Comprehensive Epilepsy Program, Rhode Island Hospital; Associate Professor of Neurology, The Warren Alpert Medical School of Brown University

Andrew S Blum, MD, PhD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Jose E Cavazos, MD, PhD, FAAN  Associate Professor with Tenure, Departments of Neurology, Pharmacology, and Physiology, Program Director of the Clinical Neurophysiology Fellowship, University of Texas School of Medicine at San Antonio; Co-Director, South Texas Comprehensive Epilepsy Center, University Hospital System; Director of the San Antonio Veterans Affairs Epilepsy Center of Excellence and Neurodiagnostic Centers, Audie L Murphy Veterans Affairs Medical Center

Jose E Cavazos, MD, PhD, FAAN is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, and American Neurological Association

Disclosure: GXC Global, Inc. Intellectual property rights Medical Director - company is to develop a seizure detecting device. No conflict with any of the eMedicine articles that I wrote or edited.

Daniel J Dire, MD, FACEP, FAAP, FAAEM  Clinical Professor, Department of Emergency Medicine, University of Texas Medical School at Houston; Clinical Professor, Department of Pediatrics, University of Texas Health Sciences Center San Antonio

Daniel J Dire, MD, FACEP, FAAP, FAAEM is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American Academy of Pediatrics, American College of Emergency Physicians, and Association of Military Surgeons of the US

Disclosure: Nothing to disclose.

J Stephen Huff, MD  Associate Professor of Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia School of Medicine

J Stephen Huff, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Edward H Maa, MD  Chief of Comprehensive Epilepsy Program, Department of Neurology, Denver Health and Hospitals; Assistant Professor, Department of Neurology, University of Colorado School of Medicine and Veterans Affairs Medical Center

Edward H Maa, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society

Disclosure: UCB Pharma Honoraria Speaking and teaching

Mark Spitz, MD  Professor, Department of Neurology, University of Colorado Health Sciences Center

Mark Spitz, MD is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, and American Epilepsy Society

Disclosure: pfizer Honoraria Speaking and teaching; ucb Honoraria Speaking and teaching; lumdbeck Honoraria Consulting

Specialty Editor Board

Erasmo A Passaro, MD, FAAN  Director, Comprehensive Epilepsy Program/Clinical Neurophysiology Lab, Bayfront Medical Center, Florida Center for Neurology

Erasmo A Passaro, MD, FAAN is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, American Medical Association, and American Society of Neuroimaging

Disclosure: Glaxo Smith Kline Honoraria Speaking and teaching; UCB Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Forest Honoraria Speaking and teaching

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Norberto Alvarez, MD  Assistant Professor, Department of Neurology, Harvard Medical School; Consulting Staff, Department of Neurology, Boston Children's Hospital; Medical Director, Wrentham Developmental Center

Norberto Alvarez, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, and Child Neurology Society

Disclosure: Nothing to disclose.

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

Chief Editor

Stephen A Berman, MD, PhD, MBA  Professor of Neurology, University of Central Florida College of Medicine

Stephen A Berman, MD, PhD, MBA is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, and Phi Beta Kappa

Disclosure: Nothing to disclose.

References

  1. Proceedings and abstracts of the First London Colloquium on Status Epilepticus, University College London, April 12-15, 2007. Epilepsia. 2007;48 Suppl 8:1-109. [Medline].

  2. Shorvon SD, Trinka E, Walker MC. The proceedings of the First London Colloquium on Status Epilepticus--University College London, April 12-15, 2007. Introduction. Epilepsia. 2007;48 Suppl 8:1-3. [Medline].

  3. Kälviäinen R. Status epilepticus treatment guidelines. Epilepsia. 2007;48 Suppl 8:99-102. [Medline].

  4. Wilson JV, Reynolds EH. Texts and documents. Translation and analysis of a cuneiform text forming part of a Babylonian treatise on epilepsy. Med Hist. Apr 1990;34(2):185-98. [Medline].

  5. Wolf P, Trinka E, Bauer G. Absence status epilepticus: the first documented case?. Epilepsia. 2007;48 Suppl 8:4-5. [Medline].

  6. Epilepsy Foundation of America. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA. Aug 18 1993;270(7):854-9. [Medline].

  7. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia. Jan 1999;40(1):120-2. [Medline].

  8. Lowenstein DH, Cloyd J. Out-of-hospital treatment of status epilepticus and prolonged seizures. Epilepsia. 2007;48 Suppl 8:96-8. [Medline].

  9. Geier S, Bancaud J, Bonis A, Enjelvin M. [Tele-E.E.G. recordings of three epileptic attacks classified as episodes of PM status (author's transl)]. Rev Electroencephalogr Neurophysiol Clin. Apr-Jun 1977;7(2):201-2. [Medline].

  10. Ellis JM, Lee SI. Acute prolonged confusion in later life as an ictal state. Epilepsia. Apr 1978;19(2):119-28. [Medline].

  11. Niedermeyer E, Fineyre F, Riley T, Uematsu S. Absence status (petit mal status) with focal characteristics. Arch Neurol. Jul 1979;36(7):417-21. [Medline].

  12. Lüders HO, Rona S, Rosenow F, et al. A semiological classification of status epilepticus. Epileptic Disord. Jun 2005;7(2):149-50. [Medline].

  13. Celesia GG. Modern concepts of status epilepticus. JAMA. Apr 12 1976;235(15):1571-4. [Medline].

  14. Treiman DM. Generalized convulsive, nonconvulsive, and focal status epilepticus. In: Feldman E, ed. Current Diagnosis in Neurology. St. Louis: Mosby-Year Book;1994:11-8.

  15. Lennox W, Lennow MA. Epilepsy and Related Disorders. Boston, MA: Little Brown;. 1960.

  16. Cascino GD. Nonconvulsive status epilepticus in adults and children. Epilepsia. 1993;34 Suppl 1:S21-8. [Medline].

  17. Shorvon S. The outcome of tonic-clonic status epilepticus. Curr Opin Neurol. Apr 1994;7(2):93-5. [Medline].

  18. White PT, Grant P, Mosier J, Craig A. Changes in cerebral dynamics associated with seizures. Neurology. Apr 1961;11(4)Pt 1:354-61. [Medline].

  19. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. Nov 1980;69(5):657-66. [Medline].

  20. Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. Jan 1973;28(1):1-9. [Medline].

  21. Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci. Aug 24 2005;25(34):7724-33. [Medline].

  22. Sloviter RS, Zappone CA, Bumanglag AV, Norwood BA, Kudrimoti H. On the relevance of prolonged convulsive status epilepticus in animals to the etiology and neurobiology of human temporal lobe epilepsy. Epilepsia. 2007;48 Suppl 8:6-10. [Medline].

  23. Goodkin HP, Sun C, Yeh JL, Mangan PS, Kapur J. GABA(A) receptor internalization during seizures. Epilepsia. 2007;48 Suppl 5:109-13. [Medline].

  24. Holmes GL. Influence of brain development on status epilepticus. Epilepsia. 2007;48 Suppl 8:19-20. [Medline].

  25. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. Jul 1995;12(4):316-25. [Medline].

  26. Shinnar S, Pellock JM, Moshe SL, et al. In whom does status epilepticus occur: age-related differences in children. Epilepsia. Aug 1997;38(8):907-14. [Medline].

  27. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. Apr 1996;46(4):1029-35. [Medline].

  28. Shorvon S. Definition, classification and frequency of status epilepticus. In: Shorvon S, ed. Epilepticus: Its Clinical Features and Treatment in Children and Adults. Cambridge: Cambridge University Press; 1994:21-33.

  29. Waterhouse EJ, DeLorenzo RJ. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging. 2001;18(2):133-42. [Medline].

  30. Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours. Epilepsia. Jan 19 2009;[Medline].

  31. Rossetti AO, Oddo M, Liaudet L, Kaplan PW. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology. Feb 24 2009;72(8):744-9. [Medline].

  32. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. Sep 17 1998;339(12):792-8. [Medline].

  33. Thomas P. How urgent is the treatment of nonconvulsive status epilepticus?. Epilepsia. 2007;48 Suppl 8:44-5. [Medline].

  34. Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia. Jun 1970;11(2):187-97. [Medline].

  35. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. Apr 2 1998;338(14):970-6. [Medline].

  36. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology. May 1990;40(5 Suppl 2):9-13. [Medline].

  37. Boggs JG, Marmarou A, Agnew JP, et al. Hemodynamic monitoring prior to and at the time of death in status epilepticus. Epilepsy Res. Aug 1998;31(3):199-209. [Medline].

  38. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. Aug 1995;45(8):1499-504. [Medline].

  39. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. Jan-Feb 1990;5(1):49-60. [Medline].

  40. Treiman DM, Meyers PD, Walton NY. DVA Status Epilepticus Cooperative Study Group. Duration of generalized convulsive status epilepticus: relationship to clinical symptomatology and response to treatment. Epilepsia. 1992;33(Suppl 3):66.

  41. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol. Jul 1995;12(4):343-62. [Medline].

  42. Bien CG, Elger CE. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord. Mar 2008;10(1):3-7. [Medline].

  43. Leis AA, Ross MA, Summers AK. Psychogenic seizures: ictal characteristics and diagnostic pitfalls. Neurology. Jan 1992;42(1):95-9. [Medline].

  44. Jagoda A, Richey-Klein V, Riggio S. Psychogenic status epilepticus. J Emerg Med. Jan-Feb 1995;13(1):31-5. [Medline].

  45. Holtkamp M, Othman J, Buchheim K, Meierkord H. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology. Jun 13 2006;66(11):1727-9. [Medline].

  46. Kutluay E, Beattie J, Passaro EA, Edwards JC, Minecan D, Milling C, et al. Diagnostic and localizing value of ictal SPECT in patients with nonconvulsive status epilepticus. Epilepsy Behav. Mar 2005;6(2):212-7. [Medline].

  47. Assal F, Papazyan JP, Slosman DO, Jallon P, Goerres GW. SPECT in periodic lateralized epileptiform discharges (PLEDs): a form of partial status epilepticus?. Seizure. Jun 2001;10(4):260-5. [Medline].

  48. Karlov VA. Complex partial status epilepticus. Epilepsia. Sep 2007;48(9):1815. [Medline].

  49. Brenner RP. EEG in convulsive and nonconvulsive status epilepticus. J Clin Neurophysiol. Sep-Oct 2004;21(5):319-31. [Medline].

  50. Kaplan PW. The EEG of status epilepticus. J Clin Neurophysiol. Jun 2006;23(3):221-9. [Medline].

  51. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. Aug 1998;39(8):833-40. [Medline].

  52. Szabo K, Poepel A, Pohlmann-Eden B, Hirsch J, Back T, Sedlaczek O, et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain. Jun 2005;128:1369-76. [Medline].

  53. Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus?. Epilepsia. 2007;48 Suppl 8:52-5. [Medline].

  54. Arif H, Hirsch LJ. Treatment of status epilepticus. Semin Neurol. Jul 2008;28(3):342-54. [Medline].

  55. Parviainen I, Uusaro A, Kalviainen R, et al. Propofol in the treatment of refractory status epilepticus. Intensive Care Med. Jul 2006;32(7):1075-9. [Medline].

  56. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. Dec 2009;37(12):3024-30. [Medline].

  57. Blumkin L, Lerman-Sagie T, Houri T, Gilad E, Nissenkorn A, Ginsberg M, et al. Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol. Mar 2005;20(3):239-41. [Medline].

  58. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. Jul 25 2006;67(2):340-2. [Medline].

  59. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology. Jan 25 2005;64(2):353-5. [Medline].

  60. Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol. 2005;54(1):34-8. [Medline].

  61. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure. Apr 2006;15(3):137-41. [Medline].

  62. Hirsch LJ. Levitating Levetiracetam's Status for Status Epilepticus. Epilepsy Curr. Sep-Oct 2008;8(5):125-6. [Medline].

  63. Bialer M. Clinical pharmacology of parenteral use of antiepileptic drugs. Epilepsia. 2007;48 Suppl 8:46-8. [Medline].

  64. Aggarwal P, Wali JP. Lidocaine in refractory status epilepticus: a forgotten drug in the emergency department. Am J Emerg Med. May 1993;11(3):243-4. [Medline].

  65. Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand. Feb 2011;123(2):142-6. [Medline].

  66. D'Giano CH, Del C Garcia M, Pomata H, Rabinowicz AL. Treatment of refractory partial status epilepticus with multiple subpial transection: case report. Seizure. Jul 2001;10(5):382-5. [Medline].

  67. Ma X, Liporace J, O'Connor MJ, Sperling MR. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res. Jul 2001;46(1):33-8. [Medline].

  68. Duane DC, Ng YT, Rekate HL, et al. Treatment of refractory status epilepticus with hemispherectomy. Epilepsia. Aug 2004;45(8):1001-4. [Medline].

  69. Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg. Apr 2001;34(4):190-2. [Medline].

  70. Costello DJ, Simon MV, Eskandar EN, Frosch MP, Henninger HL, Chiappa KH, et al. Efficacy of surgical treatment of de novo, adult-onset, cryptogenic, refractory focal status epilepticus. Arch Neurol. Jun 2006;63(6):895-901. [Medline].

  71. McIntyre J, Robertson S, Norris E, Appleton R, Whitehouse WP, Phillips B, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. Jul 16-22 2005;366(9481):205-10. [Medline].

  72. de Haan GJ, van der Geest P, Doelman G, Bertram E, Edelbroek P. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. Mar 2010;51(3):478-82. [Medline].

 
Previous
Next
 
Treatment algorithms for convulsive status epilepticus.
Focal status epilepticus. Electroencephalograph (EEG) in a patient with epilepsia partialis continua caused by Rasmussen encephalitis before hemispherectomy. The patient had long-standing, intractable partial epilepsy since the first decade of life. Seizures included complex partial with occasional secondary generalization and repetitive myoclonus involving the left side of the body. Note the frequent epileptiform discharges at 1-2 Hz involving the right frontocentral channels. These were evident on many of the patient's routine EEGs. Clinical myoclonus is often correlated with high-voltage bursts of such activity.
Focal status epilepticus. Electroencephalograph (EEG) in a 35-year-old patient with a history of intractable partial epilepsy, in complex partial status epilepticus. The patient underwent a rapid antiepileptic drug taper as an inpatient for long-term video/EEG monitoring as a presurgical candidate. On clinical observation, the patient abruptly stopped and stared, exhibiting automatisms. This first of 2 EEG fragments covers approximately 30 seconds and illustrates the start and evolution of a seizure in the right temporal lobe. The onset appears to be at Sp2 and T4. Note the time of the event, 18:35 on May 9.
Focal status epilepticus. This electroencephalographic (EEG) fragment was obtained at approximately 12:39 on May 10, 18 hours after the onset of complex partial status epilepticus originating in the right temporal lobe, in a 35-year-old patient with a history of intractable partial epilepsy. Other EEG acquisitions over the interval were identical. On clinical observation, the patient was lethargic, sluggish, and vague, with variable responsivity to examiners. Note the persistent epileptiform discharges at 1.5-2.5 Hz with phase reversal mainly at Sp2 though infrequently shifting to Sp1 and F7. The bulk of the discharges are maximal at Sp2, reflecting their mesial temporal origin, with rare, subtle, and low-amplitude reflection from lateral neocortical channels (F8). Background activities are slow with admixed beta frequencies. This finding corresponds to complex partial status epilepticus.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.